The need for greater patient engagement isn’t a new issue today. It has persisted for decades, and the struggle to optimize it is still a
In the bustling world of clinical research, where every discovery holds the promise of a brighter future, patient engagement and compliance stand as the guiding
Source: Telehealth and Medicine Today Clinical trials, the bedrock of medical research, are facing a pervasive challenge that threatens the very foundation of therapeutic development:
Source: Healthcare Business Today In the fast-evolving healthcare industry, the quest for innovative therapies is often hindered by formidable obstacles, chief among them being the
Source: HealthIT Answers The landscape of drug development is fraught with escalating costs and formidable challenges. Lengthy timelines, exorbitant expenses, and regulatory hurdles often impede
Source: BioSupply Trends Quarterly CLINICAL TRIALS are the linchpin for bringing new medications to market, and they depend on patient participation. However, stalled patient recruitment
Source: PRWeb Jeeva Clinical Trials is revolutionizing drug development by integrating AI and automated workflows into clinical trials, significantly reducing the time and cost of
Source: Pharmaceutical Outsourcing In the fast-paced world of biopharmaceuticals, emerging and mid-market companies face significant challenges when bringing innovative drugs to market. One major obstacle
Source: PRWeb Dr. Harsha Rajasimha, Founder and CEO of Jeeva Trials, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on
Source: Cision PRweb The FDA has released new guidance for decentralized clinical trials (DCTs) for drugs, biological products, and medical devices to improve DCT implementation.
